Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |